Search Results
158 items found for "IJzerman AP"
- Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report
will provide the basis for patient selection for a randomised controlled trial (RCT), including sham apheresis
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
III Molecular tools and biosensors directed at AGPCR signaling and function The NTF Release Sensor Approach Laurent Sabbagh Characterizing hADGRE5/CD97 Activation and Signaling: A Mechanical Stimulation BRET-Based Approach (MS-BRET) Ana Lilia Moreno Salinas The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets, yet no approved By leveraging self-cleavage and NTF release, the NRS technology offers a novel approach distinct from
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
This offers a novel approach to quantitatively evaluate chemokine-receptor activation and antagonism Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G Oehler , Pamela S Becker , Jacob S Appelbaum
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
The data revealed that apo-CXCR4 preferentially populates a high-FRET inactive state, while apo-ACKR3
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
Activity Published date October 14, 2024 Abstract "Regulators of G-protein signaling (RGS) are a family of approximately develop RGS2 inhibitors as potential chemotherapeutic agents utilizing structure-based drug design approaches This is the first group of RGS2 inhibitors identified by structure-based approaches and that show anticancer
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
Talquetamab, a Food and Drug Administration-approved T-cell-directing bispecific antibody developed for
- Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca2+ Flux
findings reveal a novel role of IL-8 in PEDV infection and suggest that targeting IL-8 could be a new approach
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
a non-biased zebrafish embryonic development screen and validated with Morpholino and CRISPR based approaches These findings provide a promising therapeutic approach to selectively induce ferroptosis in glioblastoma
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has
- GPCR Retreat | Dr. GPCR Ecosystem
Each year, approximately 2/3 of the participants are trainees.
- Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018
We also fitted age-period-cohort (APC) models to assess nonlinear period and cohort effects as incidence
- Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
support wider exploration of PRL3 expression in embryonal and mesenchymal tumors and further clinical application
- Structure-based discovery of functionally selective 5-HT1A receptor agonists
Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining
- Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed
cancer biology studies and retrospective human epidemiological studies suggest that two well-known, approved As a repurposing of generic drugs, this is not likely to be appealing to pharmaceutical companies and
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
protein-coupled receptors (GPCRs) are among the targets of current antifibrotic drugs, no drug has yet been approved Developing a GPR176 inverse agonist or allosteric modulator is a promising therapeutic approach for fibrosis
- The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy
Despite their crucial role in regulating antitumor immunity and tumorigenesis, therapeutic applications and discussing innovative strategies to harness the full potential of GPCR-targeted treatments, by applying
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
This approach contrasts with other antigen forms like peptides or DNA, which face limitations in structural
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
Authors Hsuan Lung, Kelly L Wentworth, Tania Moody, Ariane Zamarioli, Apsara Ram, Gauri Ganesh, Misun
- Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ
processes such as miRNA-mediated gene silencing, positive regulation of ERK cascade, hypoxia-induced apoptosis
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed Furthermore, their modulation could be considered as a promising approach in lung cancer therapeutics
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
I received my MS in Applied Toxicology from the University of Washington, and my BA in Biology from Vassar
- GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
as GPCR-omics, focused target identification, polypharmacology, and effective personalized medicine approaches Authors Nidhi V Dwivedi , Souvik Datta , Karim El-Kersh , Ruxana T Sadikot , Apar K Ganti , Surinder
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the synovium
suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic approach
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts Published date April Experimental approach: RNA sequencing and single cell qRT-PCR were performed on mouse kidneys after unilateral
- Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
One promising potential application of such mathematical models is the study of how disease-causing mutations
- Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling
date July 11, 2023 Abstract "Macrophages release soluble mediators following efferocytic clearance of apoptotic which binds to macrophage GPR37 to increase expression of the efferocytosis receptor Tim4 via an ERK-AP1
- Biased agonism at the GLP-1 receptor: from structure to animal models of disease
Recently, his team has applied cryo-EM to elucidation of the structure and dynamics of GPCRs. Prof.
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
LncRNA) PAXIP1 antisense RNA 1 (PAXIP1-AS1) was found to promote proliferation, migration, EMT, and apoptosis